Midterm 1 Drugs Flashcards
(37 cards)
Terfenadine
Brand name Seldane
Supposed non-drowsy antihistamine
Metabolized into fexofenadine in the liver (prodrug)
If not metabolized very potent hERG ion channel blocker in the heart
Potentially fatal cardiac arrhythmia (‘torsades de pointes’)
Fexofenadine
Produced through metabolism of Terfenadine
Specific non-drowsy antihistamine
Benzodiazepines
Positive allosteric modulator for GABA receptors in the brain
Used to alleviate symptoms of alcohol withdrawal
Bendroflumethiazide
Block sodium chloride symporter in the distal convoluted tubule
Preventing sodium reabsorption decreases blood volume and blood pressure
Also has direct vasodilatory effect
Propranolol
Non-selective beta blocker
Decreases cardiac output in the heart
Causes vasoconstriction of blood vessels in the lungs
Not for patients with asthma (bronchospasm)
Atenolol
Selective beta 1 blocker
Decreases cardiac output in the heart
Carvedilol
Non-selective beta and alpha blocker
Decreases cardiac output in the heart
Causes vasoconstriction of blood vessels in the lungs
Causes vasodilation of blood vessels in peripheral tissues
Not for patients with asthma (bronchospasm)
Prazosin
Selective alpha 1 blocker
Causes vasodilation of blood vessels in peripheral tissues
Amlodipine
Calcium Chanel Blocker
Decreases smooth muscle contraction (has vasodilatory effect)
Captopril
ACE inhibitor
Prevents ACE from converting ATI to ATII
ATII can’t trigger smooth muscle contraction or aldosterone release
Decrease blood volume and pressure
Side effect is dry cough due to bradykinin pathway
Losartan
AT1 Receptor Blocker (ARB)
Prevents smooth muscle contraction and aldosterone synthesis
Decreases blood pressure
Spironolactone
Competitive antagonist at the aldosterone receptor
Prevents expression of Na/K pump, ENaC and Na/Cl symporter
Decreases blood pressure
Atorvastatin
Commercial name Lipitor
Competitive inhibitor of HMG-CoA reductase
Stops cholesterol synthesis in the liver
Increases expression of LDL receptors on hepatocytes
Decreases circulating LDL
Fenofibrate
Agonist of PPAR (peroxisome proliferator-activated receptor)
Activates intracellular receptor to increase expression of lipoprotein lipase
Increases breakdowns of triglycerides in VLDLs and uptake of fatty acids in peripheral tissues
Increases LDL uptake in liver and decreases VLDL production in the liver
Acetylsalicylic Acid
Active ingredient in Aspirin
Non-selective NSAID
Irreversible competitive inhibitor of COX1 and COX2 enzymes
Prevents synthesis of PGE2 and TXA2
Analgesic, anti-inflammatory, antipyretic and blood thinning
Side effect of gastric toxicity associated with chronic use
Ketoralac
Highly efficacious non-selective NSAID
Chronic use associated with gastric toxicity
Celecoxib
Selective NSAID - COX2 inhibitor only
No gastric toxicity
Risk of cardiovascular toxicity
Acetaminophen
Weak and reversible COX1 and COX2 inhibitor
Inhibits COX3 (in cerebral cortex)
Analgesic and antipyretic but not anti-inflammatory
In overdose can lead to liver damage and death
Procain
Topical anaesthetic
Short half-life due to ester bond in linker region
Blocks sodium ion channels intracellularly
Higher affinity for active neurons
Bupivicaine
Topical anaesthetic
Blocks sodium ion channels intracellularly
Higher affinity for active neurons
Lidocaine
Topical Anaesthetic
Blocks sodium ion channels intracellularly
Higher affinity for active neurons
Capsaicin
Agonist for TRPV1 receptor
Chronic activation of receptor leads to desensitization and analgesia
Codeine
Mu opioid receptor agonist
Decreases neuronal signalling in the nucleus tractus solitarus through the Gi signalling cascade
Effective antitussive in low doses
Dextromethorphan
Centrally active NMDA receptor antagonist
Inhibits neuronal signalling in the nucleus tractus solitarus
Not very effective antitussive